Detalhe da pesquisa
1.
Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma.
Br J Haematol
; 165(3): 375-81, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24606326
2.
Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors.
Anticancer Drugs
; 24(6): 636-40, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23698253
3.
Risk assessment models for cancer-associated venous thromboembolism.
Cancer
; 118(14): 3468-76, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22086826
4.
Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.
Clin Cancer Res
; 21(11): 2480-6, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25739672